ALRN-5281

N/A

Report date: 2024/06/27 20:00:09
NME

Base Information

Drug NameALRN-5281
Drug Alias NameALRN-5281
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGrowth hormone releasing factor agonists
TargetsGrowth hormone releasing factor
Therapy Area/IndicationsGrowth hormone deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRein Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRein Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsGrowth hormone deficiency

Other Information

ATC CodeN/A
Related LinksN/A